TVGN — Tevogen Bio Holdings Balance Sheet
0.000.00%
- $228.03m
- $239.50m
- 12
- 25
- 68
- 26
Annual balance sheet for Tevogen Bio Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 7.12 | 5.48 | 1.05 | 1.28 |
Net Total Accounts Receivable | ||||
Net Total Receivables | — | — | 0 | 0.159 |
Prepaid Expenses | ||||
Total Current Assets | 7.17 | 5.84 | 1.72 | 2.36 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.143 | 1.31 | 0.929 | 0.525 |
Other Long Term Assets | ||||
Total Assets | 7.66 | 7.74 | 5.51 | 3.46 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.668 | 1.96 | 85.5 | 9.04 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 24.1 | 41.7 | 99.9 | 10.1 |
Non Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | -16.5 | -34 | -94.4 | -6.67 |
Total Liabilities & Shareholders' Equity | 7.66 | 7.74 | 5.51 | 3.46 |
Total Common Shares Outstanding | ||||
Total Preferred Shares Outstanding |